Cartesian Therapeutics Inc (RNAC)
19.12
-0.56
(-2.85%)
USD |
NASDAQ |
Nov 04, 16:00
19.12
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Total Liabilities (Quarterly): 449.20M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 449.20M |
| March 31, 2024 | 442.01M |
| December 31, 2023 | 745.23M |
| September 30, 2023 | 45.70M |
| June 30, 2023 | 74.06M |
| March 31, 2023 | 81.11M |
| December 31, 2022 | 72.06M |
| September 30, 2022 | 93.36M |
| June 30, 2022 | 98.46M |
| March 31, 2022 | 89.93M |
| December 31, 2021 | 137.36M |
| September 30, 2021 | 185.89M |
| June 30, 2021 | 184.74M |
| March 31, 2021 | 196.32M |
| December 31, 2020 | 183.44M |
| September 30, 2020 | 188.38M |
| June 30, 2020 | 88.26M |
| March 31, 2020 | 97.56M |
| Date | Value |
|---|---|
| December 31, 2019 | 91.17M |
| September 30, 2019 | 44.46M |
| June 30, 2019 | 46.89M |
| March 31, 2019 | 47.66M |
| December 31, 2018 | 49.90M |
| September 30, 2018 | 50.32M |
| June 30, 2018 | 49.18M |
| March 31, 2018 | 48.36M |
| December 31, 2017 | 49.29M |
| September 30, 2017 | 44.65M |
| June 30, 2017 | 38.84M |
| March 31, 2017 | 32.77M |
| December 31, 2016 | 34.34M |
| September 30, 2016 | 20.34M |
| June 30, 2016 | 22.54M |
| March 31, 2016 | 20.38M |
| December 31, 2015 | 159.32M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
45.70M
Minimum
Sep 2023
745.23M
Maximum
Dec 2023
186.54M
Average
98.46M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 4.173B |
| Amgen Inc | 83.36B |
| Johnson & Johnson | 108.13B |
| Regeneron Pharmaceuticals Inc | 8.116B |
| NovaBay Pharmaceuticals Inc | 4.542M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 347.74M |
| Shareholders Equity (Quarterly) | -101.46M |
| Current Ratio | 4.778 |
| Net Debt Paydown Yield | 1.10% |